Negative regulation of activin receptor signaling pathway

pathway activity — cross-omics
GO:0032926Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of activin receptor signaling pathway pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CCL2, WIPF1, and DYSF, each associated with the pathway in up to 3 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of activin receptor signaling pathway activity versus CCL2 in GBM (Pearson r = -0.29).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMCCL2 →-1.050-0.280.004.00633
COADWIPF1 →-0.657-0.563<.001<.00133
COADDYSF →-0.563-0.574<.001<.00133
COADRDX →-0.452-0.404.001.00833
GBMDAB2 →-0.716-0.322.001.00833
HNSCFGD5 →-0.622-0.328.003.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0032926 vs CCL2 — GBM

Per-sample scatter of Negative regulation of activin receptor signaling pathway activity vs CCL2 in GBM.

Explore this scatter interactively →

Exploration